Ophthalmology and Vision News

Ophthalmology and Vision Industry News including optometry, eyecare, pharma, surgical and related industry news as issued by the Send2Press Newswire service.

Ruling Affirms Patent Claim for Paragon BioTeck’s R-Phenylephrine Hydrochloride Formulation

PORTLAND, Ore., Nov. 21, 2016 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc. announces a monumental ruling handed down by the United States Patent and Trademark Office (USPTO) affirming claims made by Paragon in the patent for its R-phenylephrine hydrochloride formulation. Paragon is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies.

Paragon BioTeck, Inc. Announces Call for 2017 Koch Kellan Scholarship Applicants

PORTLAND, Ore., Sept. 1, 2016 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today a call for applications for the 2017 Koch Kellan Scholarship, awarded annually to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology. A Paragon Gives initiative, the Koch Kellan Scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs and improve the quality of lives around the world.

Hasenin Al-khersan Named 2016 Koch Kellan Scholar

PORTLAND, Ore., April 18, 2016 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., announced today that Hasenin Al-khersan has been named its 2016 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.

Paragon BioTeck Receives EN ISO 13485:2012 Certification

PORTLAND, Ore., March 29, 2016 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today that it has received EN ISO 13485:2012 certification, signifying the company’s successful implementation of an effective quality management system.

Paragon BioTeck to Attend 34th Annual J.P. Morgan Healthcare Conference

PORTLAND, Ore., Jan. 7, 2016 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, will sponsor a special reception during the J.P. Morgan 2016 Healthcare Conference, being held in San Francisco, January 11-14. The conference, which is now in its 34th year, is an invitation-only event intended to create an environment of collaboration by bringing together stakeholders in the corporate, investor and financial sectors to learn about and explore market and sector trends.

Paragon BioTeck Receives CE Mark Approval on Comfortear Lacrisolve Absorbable Punctum Plug

PORTLAND, Ore., Nov. 17, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today that it has received CE mark approval for the recently FDA cleared Comfortear(R) Lacrisolve(TM) Absorbable Punctum Plug. CE mark approval is recognized and associated with safety and performance in multiple countries.

Paragon BioTeck, Inc. Announces Corporate Citizenship Initiative, ‘Paragon Gives’

PORTLAND, Ore., Oct. 16, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announces that it will be formally launching its corporate citizenship initiative coined, Paragon Gives. On Sunday October 19, 2014, Paragon BioTeck, will kick off its newly branded corporate social responsibility initiative at the annual American Academy of Ophthalmology conference in Chicago, Ill.

Paragon BioTeck to Exhibit at American Academy of Ophthalmology Annual Meeting in Chicago

PORTLAND, Ore., Oct. 15, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, will be exhibiting at the American Academy of Ophthalmology (Booth #4550) in Chicago, Ill., on October 18 – 21.

Novel Protein May Hold Promise for Enhancing Artificial Tear Formulations

PLYMOUTH, Minn., Oct. 14, 2014 (SEND2PRESS NEWSWIRE) — SilkTears, LLC, a privately held, research-based and product-driven biotechnology company, announced today that advances in protein-based excipient technology may allow for the development of artificial tear products that will more closely represent certain characteristics of the natural makeup of the tear film, and may help the significant population of patients suffering from dry eye syndrome.

Paragon BioTeck, Inc. Receives FDA Clearance for Comfortear Lacrisolve Absorbable Punctum Plug

PORTLAND, Ore., June 25, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Comfortear(R) Lacrisolve(TM) Absorbable Punctum Plug.

The British Are Coming! UK’s Unsung Lilly Takes Over The Mint in Los Angeles for Better Vision for Children Charity Fundraiser

LOS ANGELES, Calif., June 19, 2014 (SEND2PRESS NEWSWIRE) — The British are coming! The British are coming! There will be a British invasion at The Mint, Los Angeles’ legendary cultural enclave for live music, on Saturday, July 19 when Global Journey Media presents popular UK artists, the singing duo, Unsung Lilly, in a benefit concert performance for Better Vision For Children (BVC).

Paragon BioTeck announces FDA Approved Phenylephrine Hydrochloride Ophthalmic Solution Readily Available

PORTLAND, Ore., June 4, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, announces its FDA approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil, is readily available through Bausch + Lomb or your primary wholesaler.

Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent Readily Available

PORTLAND, Ore., April 9, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, received FDA approval of Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil on March 21, 2013.

Southgate Surgery Center Offers LENSAR Advanced Laser Technology for Cataract Surgery Patients

SOUTHGATE, Mich., April 8, 2014 (SEND2PRESS NEWSWIRE) — Southgate Surgery Center in Southgate, Michigan is now offering patients the FDA-approved LENSAR(TM) Laser System, a new femtosecond laser technology designed to remove cataracts and restore vision more safely and accurately than traditional cataract surgery.

Paragon Puts Ilast® Center Stage

PORTLAND, Ore., Nov. 8, 2013 (SEND2PRESS NEWSWIRE) — Leading biopharmaceutical company Paragon BioTeck, Inc. announced today that it plans to launch its new line of products, known as Ilast(R), at the Annual American Academy of Ophthalmology meeting in New Orleans. Paragon signed an exclusive distribution agreement with Horus Pharma to supply Ilast(R) ocular care products in the U.S. last month, and the company is excited to release these products to ophthalmology professionals.

Paragon BioTeck Signs Exclusive Distribution Agreement with Horus Pharma for Ilast

PORTLAND, Ore., Oct. 9, 2013 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc. today announced that it has signed a distribution agreement with Horus Pharma for rights to supply the Ilast(R) range of its medical-grade ocular hygiene and lid care products within the United States; it begins on an exclusive basis this month.

Southgate Surgery Center Acquires ORA System for Greater Vision Correction Surgery Outcomes and Patient Satisfaction

SOUTHGATE, Mich., July 26, 2013 (SEND2PRESS NEWSWIRE) — Southgate Surgery Center announced that it has acquired the groundbreaking ORA System(R) to support its ophthalmic surgeon’s ability to bring more precise vision outcomes for patients having cataract surgery. ORA-guided procedures enable surgeons to measure the eye and refine outcomes during the procedure, rather than having to “wait and see” as with traditional cataract surgery.

Bausch + Lomb Signs Exclusive License Agreement with Paragon BioTeck for Phenylephrine

MADISON, N.J. and TIGARD, Ore., April 19, 2013 (SEND2PRESS NEWSWIRE) — Bausch + Lomb, the global eye health company and Paragon BioTeck, Inc. today announced that the companies have entered into a license agreement for Bausch + Lomb to commercialize and distribute Paragon’s phenylephrine in the United States on an exclusive basis beginning this month.

Dr. Mary Davidian to Appear on American Health Front Program on NBC

NEW WINDSOR, N.Y., June 18, 2012 (SEND2PRESS NEWSWIRE) — Mary Davidian, M.D., of Highland Ophthalmology Associates, a leading eye surgeon in the Hudson Valley, announced today that she has been invited by ‘AMERICAN HEALTH FRONT!’ to present the latest developments in corneal eye wound treatment. Dr. Davidian will be discussing her experiences using a unique alternative to surgery for corneal wound repair and healing called ProKera(R).

Paragon BioTeck, Inc.’s Online Social Networking Platform, Noble Vision Group, Incorporates Treato’s Patient-Generated Medical Database

TIGARD, Ore., June 14, 2012 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a research and development organization in the eye care industry, today announced that the company’s online community discussion forum and blog, Noble Vision Group, has added the revolutionary plug-in, Treato. The plug-in, released to developers in May, 2012, allows users to search Treato’s database of over 1 billion patient-generated social media posts, providing important insights into the side effects and efficacy of over 11,000 medications.

Need for Eye Surgery Lessened by New Corneal Wound and Healing Treatment

NEW WINDSOR, N.Y., Feb. 14, 2012 (SEND2PRESS NEWSWIRE) — Mary Davidian, M.D., of Highland Ophthalmology Associates, a leading eye surgeon in The Hudson Valley, announces offering her patients a unique corneal wound repair and healing device called ProKera(R). Today, ProKera(R) is the only medical device that can provide wound healing to patients afflicted with a damaged cornea, the outer transparent surface of the eye.

Hudson Valley, NY Doctors Offer Free Cataract Screening during National Cataract Awareness Month

NEW WINDSOR, N.Y. (SEND2PRESS NEWSWIRE) — In recognition of Cataract Awareness Month, Highland Ophthalmology Associates, in New Windsor, NY, will be offering free Cataract Screenings during the month of August, 2010. Highland Ophthalmology Associates highly encourages anyone at risk to participate in their Cataract Awareness Program.

GlassesUSA.com Sets New Standard in Customer Service

DAYTON, N.J. (SEND2PRESS NEWSWIRE) — GlassesUSA.com is setting a new standard in the e-commerce industry. The New Jersey-based online store continues to make headlines by partnering with the Better Business Bureau of New Jersey to ensure that their customers have peace of mind when purchasing their glasses. The online retailer that sells prescription glasses all over the world understands the importance of great customer service.

Topcon Introduces EyeRoute Mobile, First iPhone Application for Ophthalmic Image Management

PARAMUS, N.J. (SEND2PRESS NEWSWIRE) — Topcon Medical Systems announced today that the mobile version of its successful EyeRoute(R) Image Management Suite is now available as a dedicated iPhone application from the Apple(R) iTunes store in North America. First presented in October 2009 at the American Academy of Ophthalmology Meeting in San Francisco, EyeRoute Mobile sets the stage for connectivity on the go.

Reports Indicate Fluramene to Provide Earlier and Easier Detection of Ocular Surface Disorders

EUGENE, Ore. (SEND2PRESS NEWSWIRE) — Noble Vision Group, LLC, a research and development organization today announced reports of favorable results for the topical dye formulation, Fluramene(TM), among leading eye care professionals. Fluramene, the proprietary Fluorescein Sodium and Lissamine Green dye combination is a sterile solution packaged in a 15mL bottle with a control tip dropper. The benefits of both dyes have been studied comprehensively and are well reported as diagnostic tools used independent of each other.

New Windsor Eye Doctors Urge Eye Exams During National Glaucoma Awareness Month

NEW WINDSOR, N.Y. (SEND2PRESS NEWSWIRE) — In recognition of Glaucoma Awareness Month, Highland Ophthalmology Associates, in New Windsor, NY, will be offering free Glaucoma Screenings on Saturday, January 16, 2010. Highland Ophthalmology Associates encourages anyone at risk to please participate in their Glaucoma Awareness Program. ‘Glaucoma is like high blood pressure and diabetes – you have to check your eye pressure regularly,’ said Mary Davidian, M.D. fellowship trained ophthalmologist at Highland Ophthalmology.

Orange County, NY Doctors Urge Eye Exams During National Cataract Awareness Month

NEW WINDSOR, N.Y. (SEND2PRESS NEWSWIRE) — In recognition of Cataract Awareness Month, Highland Ophthalmology Associates, in New Windsor, NY, will be offering free Cataract Screenings during the month of August, 2009. Highland Ophthalmology Associates encourages anyone at risk to please participate in their Cataract Awareness Program. ‘Cataracts are the leading cause of visual loss in Americans 65 and older,’ said Mary Davidian, M.D. fellowship trained ophthalmologist at Highland Ophthalmology.

Affordable low vision Digital Magnifying Aids for Either Television or Computer are Introduced

SPOKANE, Wash., March 10 (SEND2PRESS NEWSWIRE) — Colligo celebrates 10 years as a leader in assistive technology with new magnification aids and lower prices on its complete product line. Colligo’s low vision magnifier for television, ezRead 200: Similar to a computer mouse, the ezRead 200 is placed directly on top of a book, newspaper or reading material to display the magnified image in full color right on a television screen. Built in LED lighting enhances the reading experience. Magnification is at a level of the higher cost CCTVs.

GlassesUSA Receives Medal from BizRate for Selling Eyeglasses

BROOKLYN, N.Y. (SEND2PRESS NEWSWIRE) — As the American economy rebuilds itself, consumers are more frugal with their money. They are hitting the internet to look for deals and also to find customer-to-customer ratings of various stores including e-commerce sites. GlassesUSA.com, an e-commerce optical store now based in Brooklyn, New York, is the latest company to receive BizRate’s customer certified medal rating.

Hudson Valley Eye Doctors Urge Eye Exams During National Glaucoma Awareness Month

NEWBURGH, N.Y., Jan. 14 (SEND2PRESS NEWSWIRE) — In recognition of Glaucoma Awareness Month, Highland Ophthalmology Associates, in Newburgh, NY, will be offering free glaucoma screenings on Saturday, January 24, 2009. Highland Ophthalmology Associates encourages anyone at risk to please participate in their Glaucoma Awareness Program.

ACE Vision Group, Inc. Announces New Global Medical Director, Dr. Marguerite McDonald

SILVER LAKE, Ohio, Oct. 30 (SEND2PRESS NEWSWIRE) — ACE Vision Group, Inc. today announced the appointment of Marguerite McDonald, M.D. as Global Medical Director. Dr. McDonald is a cornea / refractive / anterior segment specialist for Ophthalmic Consultants of Long Island, Lynbrook, NY. She is presently a Clinical Professor of Ophthalmology at New York University (NYU) in Manhattan and an Adjunct Clinical Professor of Ophthalmology at Tulane University School of Medicine in New Orleans.